Goldman Sachs Group Inc Third Harmonic Bio, Inc. Transaction History
Goldman Sachs Group Inc
- $613 Billion
- Q4 2024
A detailed history of Goldman Sachs Group Inc transactions in Third Harmonic Bio, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 106,667 shares of THRD stock, worth $374,401. This represents 0.0% of its overall portfolio holdings.
Number of Shares
106,667
Previous 69,410
53.68%
Holding current value
$374,401
Previous $940,000
16.7%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding THRD
# of Institutions
92Shares Held
40.2MCall Options Held
100Put Options Held
0-
Atlas Venture Life Science Advisors, LLC10.4MShares$36.5 Million17.65% of portfolio
-
Orbimed Advisors LLC San Diego, CA5.78MShares$20.3 Million1.61% of portfolio
-
General Atlantic LLC New York, NY3.37MShares$11.8 Million1.24% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.18MShares$11.2 Million1.53% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.93MShares$10.3 Million0.02% of portfolio
About Third Harmonic Bio, Inc.
- Ticker THRD
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,328,900
- Market Cap $142M